Kun Liao

1.0k citations
15 papers · 701 indexed · 1 hit paper · h-index 11
Topics
RNA modifications and cancer (4 papers)Epigenetics and DNA Methylation (4 papers)Cancer-related gene regulation (3 papers)

In The Last Decade

Kun Liao

13 papers receiving 699 citations

Hit Papers

Phosphorylated NFS1 weakens oxaliplatin-based chemosensit...2022202620232024202250100150200

Peers

Kun Liao
Comparison fields: 5 of 90
  • Molecular Biology 423
  • Cancer Research 215
  • Pulmonary and Respiratory Medicine 156
  • Oncology 127
  • Immunology 123
Replace Joyce V. Lee with:
Joyce V. Lee Singapore
Bahman Sadeghi Iran
Li Lü China
Brett Ewald United States
Corinna Seliger Germany
Tianhe Huang China
Grant M. Fischer United States
Run Huang China
Ji-Min Lee South Korea
Yue Zeng China
Kun Liao relative to Joyce V. Lee Singapore Joyce V. Lee's profile →
Citations per field
00.5×6.5×
Joyce V. Lee · 1×
Citations per year

Countries citing papers authored by Kun Liao

Since Specialization
Citations

This map shows the geographic impact of Kun Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Liao more than expected).

Fields of papers citing papers by Kun Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Liao. The network helps show where Kun Liao may publish in the future.

Co-authorship network of co-authors of Kun Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Liao. A scholar is included among the top collaborators of Kun Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Liao. Kun Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 0
3 4
4 5
5 44
6 73
7 27
8 23
9
Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosisbreakdown →
226
10 135
11 20
12 71
13 11
14 46
15 16

About Kun Liao

Kun Liao is a scholar working on Applied Microbiology and Biotechnology, Cancer Research and Immunology, having authored 15 papers that have together received 701 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Cancer Research (215 citations), Molecular Biology (423 citations) and Immunology (123 citations). Kun Liao has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Huai‐Qiang Ju, Rui‐Hua Xu, Junzhong Lin, Qi‐Nian Wu, Zexian Liu, Hai‐Yu Mo, Kai Yu, Jin‐Fei Lin, Xiaojun Zheng and Miao‐Zhen Qiu. Their work appears in journals such as Nature Communications, Molecular Cell and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026